Top

Current Cardiovascular Imaging Reports

Published in:

01-08-2018 | Echocardiography (F Asch and S Costa, Section Editors)

Three-Dimensional Echocardiography for Evaluation of the Right Ventricle—Updates on Image Acquisition and Analysis

Authors: Diego Medvedofsky, Eric Kruse, Victor Mor-Avi, Roberto M. Lang

Published in: Current Cardiovascular Imaging Reports | Issue 8/2018

Abstract

Purpose of Review

Review three-dimensional echocardiographic (3DE) acquisition and analysis of the right ventricular (RV) chamber, the recommended technique by the American Society of Echocardiography guidelines.

Recent Findings

3DE acquisition and analysis of RV size and function is available in the majority of clinical echocardiographic laboratories. Recent publications showed this approach provides accurate information despite the challenging chamber anatomy and physiology, when compared to magnetic resonance imaging as reference. 3DE assessment directly measures RV volumes without geometric assumptions. Accordingly, 3DE analysis was found more accurate and reproducible than conventional 2DE methodology, which measures only surrogate parameters of RV function.

Summary

RV 3DE assessment is ready for routine clinical use and has direct implications for patient management. 3DE evaluation has the potential to expand the analysis not only to traditionally parameters of size and function, but to new indices including shape, which may become a new useful diagnostic and prognostic information.

Available only for authorised users

Cohen MS, Jegatheeswaran A, Baffa JM, Gremmels DB, Overman DM, Caldarone CA, et al. Echocardiographic features defining right dominant unbalanced atrioventricular septal defect: a multi-institutional Congenital Heart Surgeons’ Society study. Circ Cardiovasc Imaging. 2013;6(4):508–13. https://doi.org/10.1161/CIRCIMAGING.112.000189.CrossRefPubMed

Cohen S, Gaddam S, Gemignani A, Wu WC, Sharma S, Choudhary G. Right ventricular function relates to functional capacity in men with atrial fibrillation and preserved left ventricular ejection fraction. Echocardiography. 2013;30(5):542–50. https://doi.org/10.1111/echo.12099.CrossRefPubMed

Damy T, Ghio S, Rigby AS, Hittinger L, Jacobs S, Leyva F, et al. Interplay between right ventricular function and cardiac resynchronization therapy: an analysis of the CARE-HF trial (Cardiac Resynchronization-Heart Failure). J Am Coll Cardiol. 2013;61(21):2153–60. https://doi.org/10.1016/j.jacc.2013.02.049. CrossRefPubMed

Finocchiaro G, Knowles JW, Pavlovic A, Perez M, Magavern E, Sinagra G, et al. Prevalence and clinical correlates of right ventricular dysfunction in patients with hypertrophic cardiomyopathy. Am J Cardiol. 2014;113(2):361–7. https://doi.org/10.1016/j.amjcard.2013.09.045.CrossRefPubMed

Guazzi M, Bandera F, Pelissero G, Castelvecchio S, Menicanti L, Ghio S, et al. Tricuspid annular plane systolic excursion and pulmonary arterial systolic pressure relationship in heart failure: an index of right ventricular contractile function and prognosis. Am J Physiol Heart Circ Physiol. 2013;305(9):H1373–81. https://doi.org/10.1152/ajpheart.00157.2013.CrossRefPubMed

Hasan BS, Lunze FI, Chen MH, Brown DW, Boudreau MJ, Rhodes J, et al. Effects of transcatheter pulmonary valve replacement on the hemodynamic and ventricular response to exercise in patients with obstructed right ventricle-to-pulmonary artery conduits. JACC Cardiovasc Interv. 2014;7(5):530–42. https://doi.org/10.1016/j.jcin.2014.02.006.CrossRefPubMed

Leong DP, Hoke U, Delgado V, Auger D, Witkowski T, Thijssen J, et al. Right ventricular function and survival following cardiac resynchronisation therapy. Heart. 2013;99(10):722–8. https://doi.org/10.1136/heartjnl-2012-303076.CrossRefPubMed

Poliacikova P, Cockburn J, Pareek N, James R, Lee L, Trivedi U, et al. Prognostic impact of pre-existing right ventricular dysfunction on the outcome of transcatheter aortic valve implantation. J Invasive Cardiol. 2013;25(3):142–5.PubMed

Pruszczyk P, Goliszek S, Lichodziejewska B, Kostrubiec M, Ciurzynski M, Kurnicka K, et al. Prognostic value of echocardiography in normotensive patients with acute pulmonary embolism. JACC Cardiovasc Imaging. 2014;7(6):553–60. https://doi.org/10.1016/j.jcmg.2013.11.004.CrossRefPubMed

10.

Saguner AM, Vecchiati A, Baldinger SH, Rueger S, Medeiros-Domingo A, Mueller-Burri AS, et al. Different prognostic value of functional right ventricular parameters in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circ Cardiovasc Imaging. 2014;7(2):230–9. https://doi.org/10.1161/CIRCIMAGING.113.000210.CrossRefPubMed

11.

Said SM, Dearani JA, Burkhart HM, Connolly HM, Eidem B, Stensrud PE, et al. Management of tricuspid regurgitation in congenital heart disease: is survival better with valve repair? J Thorac Cardiovasc Surg. 2014;147(1):412–7. https://doi.org/10.1016/j.jtcvs.2013.08.034.CrossRefPubMed

12.

Schuuring MJ, van Gulik EC, Koolbergen DR, Hazekamp MG, Lagrand WK, Backx AP, et al. Determinants of clinical right ventricular failure after congenital heart surgery in adults. J Cardiothorac Vasc Anesth. 2013;27(4):723–7. https://doi.org/10.1053/j.jvca.2012.10.022.CrossRefPubMed

13.

Schuuring MJ, van Riel AC, Vis JC, Duffels MG, van Dijk AP, de Bruin-Bon RH, et al. New predictors of mortality in adults with congenital heart disease and pulmonary hypertension: midterm outcome of a prospective study. Int J Cardiol. 2015;181:270–6. https://doi.org/10.1016/j.ijcard.2014.11.222.CrossRefPubMed

14.

Wald RM, Altaha MA, Alvarez N, Caldarone CA, Cavalle-Garrido T, Dallaire F, et al. Rationale and design of the Canadian Outcomes Registry Late After Tetralogy of Fallot Repair: the CORRELATE study. Can J Cardiol. 2014;30(11):1436–43. https://doi.org/10.1016/j.cjca.2014.06.011.CrossRefPubMed

15.

Mertens LL, Friedberg MK. Imaging the right ventricle—current state of the art. Nat Rev Cardiol. 2010;7(10):551–63. https://doi.org/10.1038/nrcardio.2010.118.CrossRefPubMed

16.

• Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, Solomon SD, Louie EK, Schiller NB Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010;23(7):685–713; quiz 86–8. doi:https://doi.org/10.1016/j.echo.2010.05.010. Right ventricular echocardiographic guidelines.

17.

• Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1–39 e14. https://doi.org/10.1016/j.echo.2014.10.003. Updated cardiac chamber quantification guidelines. CrossRefPubMed

18.

Bleeker GB, Steendijk P, Holman ER, Yu CM, Breithardt OA, Kaandorp TA, et al. Assessing right ventricular function: the role of echocardiography and complementary technologies. Heart. 2006;92(Suppl 1):i19–26. https://doi.org/10.1136/hrt.2005.082503.CrossRefPubMedPubMedCentral

19.

Ling LF, Obuchowski NA, Rodriguez L, Popovic Z, Kwon D, Marwick TH. Accuracy and interobserver concordance of echocardiographic assessment of right ventricular size and systolic function: a quality control exercise. J Am Soc Echocardiogr. 2012;25(7):709–13. https://doi.org/10.1016/j.echo.2012.03.018.CrossRefPubMed

20.

Jenkins C, Chan J, Bricknell K, Strudwick M, Marwick TH. Reproducibility of right ventricular volumes and ejection fraction using real-time three-dimensional echocardiography: comparison with cardiac MRI. Chest. 2007;131(6):1844–51. https://doi.org/10.1378/chest.06-2143.CrossRefPubMed

21.

Leibundgut G, Rohner A, Grize L, Bernheim A, Kessel-Schaefer A, Bremerich J, et al. Dynamic assessment of right ventricular volumes and function by real-time three-dimensional echocardiography: a comparison study with magnetic resonance imaging in 100 adult patients. J Am Soc Echocardiogr. 2010;23(2):116–26. https://doi.org/10.1016/j.echo.2009.11.016.CrossRefPubMed

22.

Nesser HJ, Tkalec W, Patel AR, Masani ND, Niel J, Markt B, et al. Quantitation of right ventricular volumes and ejection fraction by three-dimensional echocardiography in patients: comparison with magnetic resonance imaging and radionuclide ventriculography. Echocardiography. 2006;23(8):666–80. https://doi.org/10.1111/j.1540-8175.2006.00286.x.CrossRefPubMed

23.

Niemann PS, Pinho L, Balbach T, Galuschky C, Blankenhagen M, Silberbach M, et al. Anatomically oriented right ventricular volume measurements with dynamic three-dimensional echocardiography validated by 3-Tesla magnetic resonance imaging. J Am Coll Cardiol. 2007;50(17):1668–76. https://doi.org/10.1016/j.jacc.2007.07.031.CrossRefPubMed

24.

Sugeng L, Mor-Avi V, Weinert L, Niel J, Ebner C, Steringer-Mascherbauer R, et al. Multimodality comparison of quantitative volumetric analysis of the right ventricle. JACC Cardiovasc Imaging. 2010;3(1):10–8. https://doi.org/10.1016/j.jcmg.2009.09.017.CrossRefPubMed

25.

van der Zwaan HB, Geleijnse ML, McGhie JS, Boersma E, Helbing WA, Meijboom FJ, et al. Right ventricular quantification in clinical practice: two-dimensional vs. three-dimensional echocardiography compared with cardiac magnetic resonance imaging. Eur J Echocardiogr. 2011;12(9):656–64. https://doi.org/10.1093/ejechocard/jer107.CrossRefPubMed

26.

Tosoratti E, Badano LP, Gianfagna P, Baldassi M, Proclemer A, Capelli C, et al. Improved delineation of morphological features of arrhythmogenic right ventricular cardiomyopathy with the use of contrast-enhanced echocardiography. J Cardiovasc Med (Hagerstown). 2006;7(7):566–8. https://doi.org/10.2459/01.JCM.0000234777.03949.10.CrossRef

27.

Ota T, Fleishman CE, Strub M, Stetten G, Ohazama CJ, von Ramm OT, et al. Real-time, three-dimensional echocardiography: feasibility of dynamic right ventricular volume measurement with saline contrast. Am Heart J. 1999;137(5):958–66.CrossRefPubMed

28.

Kaminska M, Sobkowicz B, Sawicki R, Lewkowicz J, Tomaszuk-Kazberuk A, Glinska R, et al. Is real time contrast echocardiography useful for assessment of the right ventricular morphology, function, and perfusion? Echocardiography. 2015;32(7):1080–6. https://doi.org/10.1111/echo.12819.CrossRefPubMed

29.

• Medvedofsky D, Mor-Avi V, Kruse E, Guile B, Ciszek B, Weinert L, et al. Quantification of right ventricular size and function from contrast-enhanced three-dimensional echocardiographic images. J Am Soc Echocardiogr. 2017;30(12):1193–202. https://doi.org/10.1016/j.echo.2017.08.003. Three-dimensional echocardiographic validation study using contrast anhancing agents. CrossRefPubMed

30.

Kim J, Cohen SB, Atalay MK, Maslow AD, Poppas A. Quantitative assessment of right ventricular volumes and ejection fraction in patients with left ventricular systolic dysfunction by real time three-dimensional echocardiography versus cardiac magnetic resonance imaging. Echocardiography. 2015;32(5):805–12. https://doi.org/10.1111/echo.12715.CrossRefPubMed

31.

Seguela PE, Hascoet S, Brierre G, Bongard V, Acar P. Feasibility of three-dimensional transthoracic echocardiography to evaluate right ventricular volumes in children and comparison to left ventricular values. Echocardiography. 2012;29(4):492–501. https://doi.org/10.1111/j.1540-8175.2011.01596.x.CrossRefPubMed

32•.

. Medvedofsky D, Addetia K, Patel AR, Sedlmeier A, Baumann R, Mor-Avi V, et al. Novel approach to three-dimensional echocardiographic quantification of right ventricular volumes and function from focused views. J Am Soc Echocardiogr. 2015;28(10):1222–31. https://doi.org/10.1016/j.echo.2015.06.013. Three-dimensional echocardiographic validation study vs cardiac magnetic resonance imaging. CrossRefPubMed

33.

• Muraru D, Spadotto V, Cecchetto A, Romeo G, Aruta P, Ermacora D, et al. New speckle-tracking algorithm for right ventricular volume analysis from three-dimensional echocardiographic data sets: validation with cardiac magnetic resonance and comparison with the previous analysis tool. Eur Heart J Cardiovasc Imaging. 2016;17(11):1279–89. https://doi.org/10.1093/ehjci/jev309. Three-dimensional echocardiographic validation study vs cardiac magnetic resonance imaging. CrossRefPubMed

34.

Taylor AQ, Messner AA. Algorithm 550, solid polyhedron measures. ACM Trans Math Softw. 1980;6:121–30.CrossRef

35.

Mor-Avi V, Jenkins C, Kuhl HP, Nesser HJ, Marwick T, Franke A, et al. Real-time 3-dimensional echocardiographic quantification of left ventricular volumes: multicenter study for validation with magnetic resonance imaging and investigation of sources of error. JACC Cardiovasc Imaging. 2008;1(4):413–23. https://doi.org/10.1016/j.jcmg.2008.02.009.CrossRefPubMed

36.

Addetia K, Maffessanti F, Yamat M, Weinert L, Narang A, Freed BH, et al. Three-dimensional echocardiography-based analysis of right ventricular shape in pulmonary arterial hypertension. Eur Heart J Cardiovasc Imaging. 2016;17(5):564–75. https://doi.org/10.1093/ehjci/jev171.CrossRefPubMed

37.

• Addetia K, Uriel N, Maffessanti F, Sayer G, Adatya S, Kim GH, et al. 3D morphological changes in LV and RV during LVAD ramp studies. JACC Cardiovasc Imaging. 2018;11(2 Pt 1):159–69. https://doi.org/10.1016/j.jcmg.2016.12.019. Three-dimensional echocardiographic shape analysis of the left and right ventricles in LVADs patients. CrossRefPubMed

Title: Three-Dimensional Echocardiography for Evaluation of the Right Ventricle—Updates on Image Acquisition and Analysis
Authors: Diego Medvedofsky
Eric Kruse
Victor Mor-Avi
Roberto M. Lang
Publication date: 01-08-2018
Publisher: Springer US
Published in: Current Cardiovascular Imaging Reports / Issue 8/2018
Print ISSN: 1941-9066
Electronic ISSN: 1941-9074
DOI: https://doi.org/10.1007/s12410-018-9460-6

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Three-Dimensional Echocardiography for Evaluation of the Right Ventricle—Updates on Image Acquisition and Analysis

Abstract

Purpose of Review

Recent Findings

Summary

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page